He M - Search Results

1

Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening.

Nilubol N, Zhang L, Shen M, Zhang YQ, He M, Austin CP, Kebebew E. Nilubol N, et al. Among authors: he m. J Transl Med. 2012 Sep 21;10:198. doi: 10.1186/1479-5876-10-198. J Transl Med. 2012. PMID: 22999104 Free PMC article.

2

Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing.

Zhang L, He M, Zhang Y, Nilubol N, Shen M, Kebebew E. Zhang L, et al. Among authors: he m. J Clin Endocrinol Metab. 2012 Mar;97(3):E319-28. doi: 10.1210/jc.2011-2671. Epub 2011 Dec 14. J Clin Endocrinol Metab. 2012. PMID: 22170715 Free PMC article.

3

Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma.

Jain M, Zhang L, He M, Patterson EE, Nilubol N, Fojo AT, Joshi B, Puri R, Kebebew E. Jain M, et al. Among authors: he m. Cancer. 2012 Nov 15;118(22):5698-708. doi: 10.1002/cncr.27629. Epub 2012 May 8. Cancer. 2012. PMID: 22570059 Free PMC article.

4

TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.

Jain M, Zhang L, He M, Zhang YQ, Shen M, Kebebew E. Jain M, et al. Among authors: he m. Endocr Relat Cancer. 2013 May 21;20(3):361-70. doi: 10.1530/ERC-12-0403. Print 2013 Jun. Endocr Relat Cancer. 2013. PMID: 23533247 Free PMC article.

5

Molecular pathways associated with mortality in papillary thyroid cancer.

Nilubol N, Sukchotrat C, Zhang L, He M, Kebebew E. Nilubol N, et al. Among authors: he m. Surgery. 2011 Dec;150(6):1023-31. doi: 10.1016/j.surg.2011.09.021. Surgery. 2011. PMID: 22136817 Free PMC article.

6

Prospective screening in familial nonmedullary thyroid cancer.

Sadowski SM, He M, Gesuwan K, Gulati N, Celi F, Merino MJ, Nilubol N, Kebebew E. Sadowski SM, et al. Among authors: he m. Surgery. 2013 Dec;154(6):1194-8. doi: 10.1016/j.surg.2013.06.019. Epub 2013 Aug 23. Surgery. 2013. PMID: 23978593 Free PMC article. Clinical Trial.

7

MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors.

Patel D, Boufraqech M, Jain M, Zhang L, He M, Gesuwan K, Gulati N, Nilubol N, Fojo T, Kebebew E. Patel D, et al. Among authors: he m. Surgery. 2013 Dec;154(6):1224-8; discussion 1229. doi: 10.1016/j.surg.2013.06.022. Surgery. 2013. PMID: 24238045 Free PMC article.

8

miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3.

Boufraqech M, Zhang L, Jain M, Patel D, Ellis R, Xiong Y, He M, Nilubol N, Merino MJ, Kebebew E. Boufraqech M, et al. Among authors: he m. Endocr Relat Cancer. 2014 Aug;21(4):517-31. doi: 10.1530/ERC-14-0077. Epub 2014 Apr 29. Endocr Relat Cancer. 2014. PMID: 24781864 Free PMC article.

9

The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.

Patterson E, Webb R, Weisbrod A, Bian B, He M, Zhang L, Holloway AK, Krishna R, Nilubol N, Pacak K, Kebebew E. Patterson E, et al. Among authors: he m. Endocr Relat Cancer. 2012 Apr 10;19(2):157-66. doi: 10.1530/ERC-11-0308. Print 2012 Apr. Endocr Relat Cancer. 2012. PMID: 22241719 Free PMC article.

10

Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer.

He M, Bian B, Gesuwan K, Gulati N, Zhang L, Nilubol N, Kebebew E. He M, et al. Thyroid. 2013 Mar;23(3):301-7. doi: 10.1089/thy.2012.0270. Thyroid. 2013. PMID: 23009101 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,986 results

Search Page

Filters